An estimated 50 to 60 scientists work on each floor of the medical research center, designed to foster "science with an open ...

Pre-built spaces and a private club atmosphere are drawing tenants to Chelsea office building 28&7. Discover the strategy behind its leasing success.

Right before the Super Bowl began in New Orleans, one of the most interesting commercials featured Martha Stewart. The ...

It recently reported positive late-stage results for the drug in treating early Parkinson's disease. Prosper Junior Bakiny (Amgen): What to do when a biotech's shares fall off a cliff following ...

Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...

Amgen provided 2025 guidance, expecting revenues between $34.3 billion and $35.7 billion and non-GAAP EPS between $20 and $21.20. Management anticipates continued growth in key products like ...

My name is Julianne, and I will be your conference facilitator today for Amgen's fourth quarter and full year 2024 financial results conference call. All lines have been placed on mute to prevent ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The company’s shares closed yesterday at $289.02.

Amgen's forward guidance anticipates continued growth, forecasting 2025 revenues between $34.3 billion and $35.7 billion, with adjusted EPS projected between $20 and $21.20. These projections ...